Buchumschlag

Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe

Background/aim: Ultra-orphan diseases (UODs) have been defined by a prevalence of less than 1 per 50,000 persons. However, little is known about budget impact of ultra-orphan drugs. Methods: For analysis, the budget impact analysis (BIA) had a time horizon of 10 years (2012-2021) and a pan-European...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schlander, Michael (VerfasserIn) , Adarkwah-Yiadom, Charles Christian (VerfasserIn) , Gandjour, Afschin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Expert review of pharmacoeconomics and outcomes research
Year: 2015, Jahrgang: 15, Heft: 1, Pages: 171-179
ISSN:1744-8379
DOI:10.1586/14737167.2015.965156
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1586/14737167.2015.965156
Volltext
Verfasserangaben:Michael Schlander, Charles Christian Adarkwah and Afschin Gandjour
Beschreibung
Zusammenfassung:Background/aim: Ultra-orphan diseases (UODs) have been defined by a prevalence of less than 1 per 50,000 persons. However, little is known about budget impact of ultra-orphan drugs. Methods: For analysis, the budget impact analysis (BIA) had a time horizon of 10 years (2012-2021) and a pan-European payer’s perspective, based on prevalence data for UODs for which patented drugs are available and/or for which drugs are in clinical development. Results: A total of 18 drugs under patent protection or orphan drug designation for non-oncological UODs were identified. Furthermore, 29 ultra-orphan drugs for non-oncological diseases under development that have the potential of reaching the market by 2021 were found. Total budget impact over 10 years was estimated to be €15,660 and €4965 million for approved and pipeline ultra-orphan drugs, respectively (total: €20,625 million). Conclusion: The analysis does not support concerns regarding an uncontrolled growth in expenditures for drugs for UODs.
Beschreibung:Online veröffentlicht: 14. Oktober 2014
Gesehen am 28.08.2017
Beschreibung:Online Resource
ISSN:1744-8379
DOI:10.1586/14737167.2015.965156

Ähnliche Einträge